Achieve Life Sciences: Smoking Cessation trials
The registry lists 10 Smoking Cessation studies with Achieve Life Sciences as lead sponsor. 0 are open to participants now and 7 have results posted.
Phase 1 6Phase 2 2Phase 3 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Second Study of Cytisinicline for Smoking Cessation in Adult SmokersCompletedNCT05206370Phase 3Results posted
- A Study of Cytisinicline for Smoking Cessation in Adult SmokersCompletedNCT04576949Phase 3Results posted
- A Single Dose-escalation Study of Cytisine in Adult SmokersCompletedNCT03848208Phase 1Results posted
- Trial of Cytisine in Adult SmokersCompletedNCT03709823Phase 2Results posted
- A Study in Healthy Smokers to Investigate the Effect of Food on the Bioavailability of Cytisine in a New FormulationCompletedNCT03509948Phase 1Results posted
- A Pharmacokinetic and Pharmacodynamic Evaluation of Cytisine in Healthy SmokersTerminatedNCT03303911Phase 1/2Results posted
- A Study in Healthy Volunteers to Investigate the Effect of Food on the Bioavailability of CytisineCompletedNCT03268343Phase 1Results posted
- Safety Study of Cytisinicline in Adult Combustible and/or E-cigarette SmokersCompletedNCT06435221Phase 3
- Study to Evaluate Effect of Food on Bioavailability of Single 3 mg Tablet and Pharmacokinetics (PK) of Multiple 3 mg Doses in Healthy Adult SmokersCompletedNCT05981768Phase 1
- Study to Evaluate Electrocardiographic Effects of Therapeutic & Supratherapeutic Doses of Cytisinicline in Healthy SmokersCompletedNCT05566288Phase 1